New IV iron therapy could help kids with anemia who Can't take pills
NCT ID NCT05179226
First seen Apr 22, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tests an intravenous (IV) iron medicine called ferric derisomaltose in children aged 0 to 18 with iron deficiency anemia. It is for kids who either have chronic kidney disease or cannot take or do not respond to oral iron. The goal is to see if the treatment safely raises hemoglobin levels. About 200 children will receive one or two doses and be followed for around 10 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY, ANAEMIA IN CHILDREN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pharmacosmos Investigational Site
RECRUITINGMiami, Florida, 33142, United States
Conditions
Explore the condition pages connected to this study.